Results 11 to 20 of about 1,340,339 (303)

Adverse Events in Pediatric Inpatients: The Japan Adverse Event Study

open access: yesJournal of Patient Safety, 2023
Objectives Adverse events (AEs) represent an important cause of morbidity and mortality for pediatric inpatients; however, reports on their epidemiology in pediatrics, especially outside Western countries, are scarce. We investigated the incidence and nature of AEs in pediatric inpatients in Japan.
Sakuma, Mio   +6 more
openaire   +2 more sources

Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial

open access: yesTrials, 2020
Background Safety data is required to be collected in all clinical trials and can be separated into two types of data, adverse events and serious adverse events.
Elizabeth C. James   +4 more
doaj   +1 more source

Adverse Events in NMOSD Therapy [PDF]

open access: yesInternational Journal of Molecular Sciences, 2022
Neuromyelitis optica spectrum disorders (NMOSD) are rare neurologic autoimmune diseases that have a poor prognosis if left untreated. For many years, generic oral immunosuppressants and repurposed monoclonal antibodies that target the interleukin-6 pathway or B cells were the mainstays of drug treatment.
Katrin Giglhuber, Achim Berthele
openaire   +2 more sources

Global Assessment of Pediatric Patient Safety Tool for identifying safety incidents in pediatric patients [PDF]

open access: yesRevista Paulista de Pediatria, 2023
Objective: The aim of this study was to evaluate the accuracy of the Global Assessment of Pediatric Patient Safety (GAPPS) in order to identify patient safety incidents with patient harm or adverse events (AEs).
Marilise Borges Brandão   +2 more
doaj   +1 more source

Gastrointestinal adverse events of immunotherapy

open access: yesBJR|Open, 2021
Cancer immunotherapy with immune-checkpoint inhibitors (ICIs) has emerged as an effective treatment for different types of cancer. ICIs are monoclonal antibodies that inhibit the signaling pathway that suppress antitumor T-cell activity. Patients benefit from increased overall and progression-free survival, but the enhancement of normal immunity can ...
Cappello, Giovanni   +5 more
openaire   +4 more sources

Fluoroquinolone antibiotics and adverse events [PDF]

open access: yesAustralian Prescriber, 2021
Fluoroquinolones are broad-spectrum antibiotics with good oral bioavailability. They are used for the treatment of a wide variety of infections, but there are restrictions on prescribing these drugs. Epidemiological studies have reported an increased risk of rare adverse effects.
Michelle Ananda-Rajah, Diva Baggio
openaire   +3 more sources

Prospective review of 30-day morbidity and mortality in a paediatric neurosurgical unit [PDF]

open access: yes, 2017
Purpose: The purpose of this study is to record the 30-day and inpatient morbidity and mortality in paediatric patients in a tertiary neuroscience centre over a 2-year period.
Beez, Thomas   +2 more
core   +2 more sources

Reducing preventable adverse events in obstetrics by improving interprofessional communication skills – Results of an intervention study

open access: yesBMC Pregnancy and Childbirth, 2023
Background Progress in medicine involves the structured analysis and communication of errors. Comparability between the individual disciplines is only possible to a limited extent and obstetrics plays a special role: the expectation of a self-determined ...
Beate Hüner   +7 more
doaj   +1 more source

Do Assets Help Families Cope With Adverse Events? [PDF]

open access: yes, 2009
Compares the extent to which families with liquid assets are better able to maintain their material well-being when adverse events affecting income such as job loss or illness occurs than families without assets.
Caroline Ratcliffe   +2 more
core   +2 more sources

Ocular Vascular Events following COVID-19 Vaccines: A Systematic Review

open access: yesVaccines, 2022
The main aim of this study is to investigate the current evidence regarding the association between COVID-19 vaccination and ocular vascular events. The protocol is registered on PROSPERO (CRD42022358133).
Hashem Abu Serhan   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy